Literature DB >> 6988136

Clinical pharmacokinetics of digoxin 1980.

J K Aronson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6988136     DOI: 10.2165/00003088-198005020-00002

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


× No keyword cloud information.
  86 in total

1.  Quantitation of digoxigenin in serum following oral administration of digoxin in humans.

Authors:  J C Loo; I J McGilveray; N Jordan
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1977-07

2.  Excretion of drugs in human milk.

Authors:  M Levy; L Granit; N Laufer
Journal:  N Engl J Med       Date:  1977-10-06       Impact factor: 91.245

3.  Digoxin kinetics in patients with thyroid dysfunction.

Authors:  J R Lawrence; D J Sumner; W J Kalk; W A Ratcliffe; B Whiting; K Gray; M Lindsay
Journal:  Clin Pharmacol Ther       Date:  1977-07       Impact factor: 6.875

4.  Dose-independent pharmacokinetics of digoxin in humans.

Authors:  H R Ochs; D J Greenblatt; G Bodem; J S Harmatz
Journal:  Am Heart J       Date:  1978-10       Impact factor: 4.749

5.  Effects of maintenance digoxin therapy on systolic time intervals and serum digoxin concentrations.

Authors:  N H Carliner; C A Gilbert; A W Pruitt; L I Goldberg
Journal:  Circulation       Date:  1974-07       Impact factor: 29.690

6.  Superior bioavailability of digoxin solution in capsules.

Authors:  G I Mallis; D H Schmidt; J Lindenbaum
Journal:  Clin Pharmacol Ther       Date:  1975-12       Impact factor: 6.875

7.  Human serum and myocardium digoxin.

Authors:  G Härtel; K Kyllönen; E Merikallio; K Ojala; V Manninen; P Reissell
Journal:  Clin Pharmacol Ther       Date:  1976-02       Impact factor: 6.875

8.  Dose-response relation between therapeutic levels of serum digoxin and systolic time intervals.

Authors:  R J Hoeschen; T E Cuddy
Journal:  Am J Cardiol       Date:  1975-04       Impact factor: 2.778

9.  Spironolactone-induced changes in digoxin kinetics.

Authors:  S Waldorff; J D Andersen; N Heebøll-Nielsen; O G Nielsen; E Moltke; U Sørensen; E Steiness
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

10.  Human myocardium and plasma digoxin concentration in patients on long-term digoxin therapy.

Authors:  J Lichey; C Havestatt; J Weinmann; J Hasford; N Rietbrock
Journal:  Int J Clin Pharmacol Biopharm       Date:  1978-10
View more
  23 in total

Review 1.  Therapeutic drug monitoring in pregnancy: rationale and current status.

Authors:  C Knott; F Reynolds
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

2.  Drug treatment of cardiac failure.

Authors:  M R Achong; C R Kumana
Journal:  Can Fam Physician       Date:  1982-01       Impact factor: 3.275

Review 3.  Guide to drug dosage in renal failure.

Authors:  W M Bennett
Journal:  Clin Pharmacokinet       Date:  1988-11       Impact factor: 6.447

4.  Effect of lacosamide on the steady-state pharmacokinetics of digoxin: results from a phase I, multiple-dose, double-blind, randomised, placebo-controlled, crossover trial.

Authors:  Willi Cawello; Christa Mueller-Voessing; Jens-Otto Andreas
Journal:  Clin Drug Investig       Date:  2014-05       Impact factor: 2.859

5.  Lack of interaction between valaciclovir, the L-valyl ester of aciclovir, and digoxin.

Authors:  J H Soul-Lawton; B C Weatherley; J Posner; G Layton; R W Peck
Journal:  Br J Clin Pharmacol       Date:  1998-01       Impact factor: 4.335

6.  Clinical pharmacokinetics: a simplified approach, Part 2.

Authors:  E Perlin; R E Taylor; C C Peck
Journal:  J Natl Med Assoc       Date:  1986-09       Impact factor: 1.798

Review 7.  Evaluation of in vivo P-glycoprotein phenotyping probes: a need for validation.

Authors:  Joseph D Ma; Shirley M Tsunoda; Joseph S Bertino; Meghana Trivedi; Keola K Beale; Anne N Nafziger
Journal:  Clin Pharmacokinet       Date:  2010-04       Impact factor: 6.447

Review 8.  The effect of respiratory disorders on clinical pharmacokinetic variables.

Authors:  A M Taburet; C Tollier; C Richard
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

9.  Pharmacokinetics of digoxin in pregnancy.

Authors:  A M Luxford; G S Kellaway
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

Review 10.  Interpretation of drug levels in acute and chronic disease states.

Authors:  E Perucca; R Grimaldi; A Crema
Journal:  Clin Pharmacokinet       Date:  1985 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.